Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 3
A Randomized Controlled, Open-Label, Rater-Blinded Pragmatic Trial, Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
The purpose of this research is to evaluate if early vs rescue Therapeutic Plasma Exchange (PLEX) treatment algorithm leads to better visual outcomes in severe…
Optic NeuritisMyelitisMyelitis, Transverse
Estimated
~$10 – $6,250
Mayo ClinicNCT07100990
Phase 3
A Randomized, Double-masked, Placebo-controlled Study Assessing the Efficacy and Safety of Privosegtor (OCS-05) in Patients With Optic Neuritis (ON)
The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (…
Optic Neuritis
Estimated
~$10 – $7,500
OculisNCT07623668
Phase 2
A Pilot Randomized Trial of Efgartigimod Alfa for the Treatment of Incident Moderate to Severe Acute Optic Neuritis
The goal of this pilot clinical trial is to test efgartigimod alfa against placebo in adults with first-time optic neuritis (optic nerve inflammation). The mai…
Optic Neuritis
Estimated
~$10 – $7,500
Anastasia Vishnevetsky, MD, MPHNCT06453694
Phase 2
A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis
The main purpose of this study is to assess clemastine as a remyelinating agent in patients with acute optic neuritis.The study will also evaluate the tolerabi…
Optic Neuritis
Estimated
~$10 – $5,625
University of California, San FranciscoNCT02521311